These data corroborate findings in IVIg-treated patients with common variable immunodeficiency (CVID) which showed that FcγRIIb mRNA expression of circulating monocytes did not change upon low-dose IVIg treatment (27). The gene discussed is FCGR2B; the disease is common variable immunodeficiency.